Common side effects documented across GLP-1 clinical trials include nausea, vomiting, diarrhea, constipation, and injection-site reactions
Tambin se ha investigado la sermorelina en adultos mayores en el contexto de la disminucin de GH asociada a la edad (la denominada "somatopausia")
C0, free carnitine
Barchini J, Tchachaghian S, Shamaa F, Jabbur SJ, Meyerson BA, Song Z, et al
The investigators found that compared with metformin, GLP-1 RA therapy was associated with the following: A 26% reduction in all-cause mortality A 13% reduction in hospitalizations Up to a 48% reduction in amputations An approximately 36% reduction in revascularization procedures in obstructed lower extremity arteries Rates of myocardial infarction, stroke, and serious kidney events were similar between the treatment groups
GSH-treated fat grafts present a better histological structure H&E staining showed that the fat grafts in the GSH-treated group exhibited better morphologic integrity, with fewer vacuoles, fibrotic cells, and inflammatory cells (Fig